The association of Health-Related Quality of Life and 1-year-survival in sarcoma patients—results of a Nationwide Observational Study (PROSa)
Open Access
- 20 January 2022
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 126 (9), 1346-1354
- https://doi.org/10.1038/s41416-022-01702-z
Abstract
Background Sarcomas are rare cancers of high heterogeneity. Health-Related Quality of Life (HRQoL) has been shown to be a prognostic factor for survival in other cancer entities but it is unclear whether this applies to sarcoma patients. Patients and methods HRQoL was prospectively assessed in adult sarcoma patients from 2017 to 2020 in 39 German recruiting sites using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30). Vital status was ascertained over the course of 1 year. HRQoL domains were analysed by multivariable cox-regressions including clinical and socio-economic risk factors. Results Of 1102 patients, 126 (11.4%) died during follow-up. The hazard ratio (HR) for global health was 0.73 per 10-point increase (95% confidence interval (CI) 0.64–0.85). HR for the HRQoL-summary score was 0.74 (CI 0.64–0.85) and for physical functioning 0.82 (CI 0.74–0.89). There was also evidence that fatigue (HR 1.17, CI 1.10–1.25), appetite loss (HR 1.15, CI 1.09–1.21) and pain (HR 1.14, CI 1.08–1.20) are prognostic factors for survival. Conclusion Our study adds sarcoma-specific evidence to the existing data about cancer survival in general. Clinicians and care-givers should be aware of the relations between HRQoL and survival probability and include HRQoL in routine assessment.Keywords
Funding Information
- Deutsche Krebshilfe (111713)
This publication has 24 references indexed in Scilit:
- Prediction of Quality of Life and Survival After Surgery for Symptomatic Spinal MetastasesNeurosurgery, 2015
- Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robustJournal of Clinical Epidemiology, 2015
- The longitudinal relationship between quality of life and survival in advanced stage cancerPsycho‐Oncology, 2015
- Symptomatic Toxicities Experienced During Anticancer Treatment: Agreement Between Patient and Physician Reporting in Three Randomized TrialsJournal of Clinical Oncology, 2015
- Patient- versus physician-reporting of symptoms and health status in chronic myeloid leukemiaHaematologica, 2013
- Descriptive epidemiology of sarcomas in Europe: Report from the RARECARE projectEuropean Journal of Cancer, 2012
- Prevalence, predictors, and prognostic impact of fatigue among Brazilian outpatients with advanced cancersSupportive Care in Cancer, 2012
- The Hazards of Hazard RatiosEpidemiology, 2010
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2008
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993